Jon P. Stonehouse
President & CEO at BioCryst Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director · Chief Executive Officer
Chief executive roles
BioCryst Pharmaceuticals Inc.
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| May 29, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +631 | $8.91 | $5,622 |
| Mar 2, 2026 | BioCryst Pharmaceuticals Inc. | Option exercise | +305,995 | $3.22 | $985,304 |
| Mar 2, 2026 | BioCryst Pharmaceuticals Inc. | Sold back to the company | −305,995 | $8.64 | $2,643,797 |
| Feb 27, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +421 | $8.75 | $3,684 |
| Dec 19, 2025 | BioCryst Pharmaceuticals Inc. | Shares withheld for tax | −61,793 | $7.41 | $457,886 |
| Dec 18, 2025 | BioCryst Pharmaceuticals Inc. | Gift | −20,000 | — | — |
| Dec 18, 2025 | BioCryst Pharmaceuticals Inc. | Gift | +10,000 | — | — |
| Dec 18, 2025 | BioCryst Pharmaceuticals Inc. | Gift | +10,000 | — | — |
| Dec 12, 2025 | BioCryst Pharmaceuticals Inc. | Shares withheld for tax | −27,368 | $7.57 | $207,176 |
| Dec 20, 2024 | BioCryst Pharmaceuticals Inc. | Gift | −20,000 | — | — |
| Dec 20, 2024 | BioCryst Pharmaceuticals Inc. | Gift | +10,000 | — | — |
| Dec 20, 2024 | BioCryst Pharmaceuticals Inc. | Gift | +10,000 | — | — |
| Dec 19, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +362,100 | — | — |
| Dec 19, 2024 | BioCryst Pharmaceuticals Inc. | Shares withheld for tax | −14,010 | $7.39 | $103,534 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.